Template talk:DNA antivirals

This template does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Medicine This template is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles

This template survived a discussion at TfD. Several editors said it should be 'flattened' in some way. The debate can be found here. -Splash^talk 19:46, 20 November 2005 (UTC)[reply]

Done. --Arcadian 19:23, 1 January 2006 (UTC)[reply]

Should viricides be added to this template? -- stillnotelf has a talk page 02:00, 1 February 2006 (UTC)[reply]

I'm not sure, but I'd reckon not. This template seems to be for drugs taken internally. Perhaps ask Ben.c.roberts, the user who originated it ..?  Best wishes, David Kernow 18:11, 1 February 2006 (UTC)[reply]

I also tend towards no, I just thought it should be brought up. -- stillnotelf has a talk page 23:28, 1 February 2006 (UTC)[reply]

I propose this template be split into HIV and non-HIV antivirals. It's getting very big. User:Hopping ^T 04:09, 30 November 2007 (UTC)[reply]

You can see what I created at Template:HIVpharm.User:Hopping ^T 22:26, 3 December 2007 (UTC)[reply]

I think that's a pretty good idea. Fvasconcellos (t·c) 22:39, 3 December 2007 (UTC)[reply]

NOV-002 is currently in Phase III under Fast Track Special Protocol Assessment. why are you saying Never to Phase III?

http://clinicaltrials.gov/show/NCT00347412

Fully enrolled Phase III trial link supplied.

Bixbyte (talk) 16:27, 24 October 2009 (UTC)Bixbyte[reply]